![Vivek Khanna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Vivek Khanna is an Investment Partner at PFM Health Sciences LP.
Prior to joining PFM in 2012, Mr. Khanna was an Analyst at Catapult Partners/Millennium LLP (2011-2012).
Before Millennium, he was an Analyst /Sector Head at Argus/Sivik Healthcare (2002-2011).
Prior to Sivik Healthcare, he was an Executive Director of Equity Research with UBS Investment Bank (1999-2002), Vice President of Equity Research with Smith Barney (1993-1996) and an Analyst at Blue Cross Blue Shield of National Capital Area (1991-1993).
He is a graduate of Delhi University with a B.A. in Economics and received his MBA from the College of William and Mary.
Postes actifs de Vivek Khanna
| Sociétés | Poste | Début |
|---|---|---|
PFM Health Sciences LP
 PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Analyst-Equity | 01/01/2012 |
Formation de Vivek Khanna
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
PFM Health Sciences LP
PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Finance |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delhi
 University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
